PAQ

PAQ

Private
Burlington, MassachusettsHealthcare & Life Scienceswww.paqtx.com

Last Round

Series B

Extension

Jan 22, 2026

Total Funding Raised

$111M

Company Overview

PAQ Therapeutics is a biotechnology company focused on restoring health and curing diseases through innovative autophagy-based therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

targeted protein degradationKRAS degradersautophagysmall-molecule therapiesTPDPac-Man drugsprotein degradersoncology therapeuticsATTEC platformautophagy-dependent degradationdrug discoveryneurodegenerative disordersclinical-stage biotechKRAS G12D degrader

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PAQ Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PAQ Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionJan 22, 2026
Series BMay 7, 2025
Series AJul 15, 2021
SeedNov 8, 2020

PAQ Investors

Notable investors and investment history

InvestorRounds
MatrixSeed, Series A
BioTrack CapitalSeries B Extension, Series B
MRL Ventures FundSeries B Extension, Series A, Series B
MRLVSeries A, Series B
Nest Bio VenturesSeed, Series A
MSA CapitalSeries A
Bayland CapitalSeries B Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2025

    Partnering with Insilico Medicine to develop novel therapies.

PAQ Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PAQ Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PAQ's valuation, stock price, and market status.

Firmographic Details

HeadquartersBurlington, Massachusetts
Employee Range11
Year Founded2020
Last FundingJan 22, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.